Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 1.00 |
| ▸ | LMNA | P02545 | 5/20 | 1.00 |
| ▸ | MEN1 | O00255 | 5/20 | 1.00 |
| ▸ | HTT | P42858 | 5/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 5/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 1.00 |
| ▸ | HSP90AA1 | P07900 | 5/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | METAP2 | P50579 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 1.00 |
| ▸ | TP53 | P04637 | 3/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 3/20 | 1.00 |
| ▸ | MMP14 | P50281 | 3/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 3/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 3/20 | 1.00 |
| ▸ | USP2 | O75604 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Clioquinol SCHEMBL29370380 | 1.00 | KDM4E (1.00) | KDM4ELMNAMEN1HTTKMT2A | |
| Clioquinol SCHEMBL30592904 | 1.00 | KDM4E (1.00) | KDM4ELMNAMEN1HTTKMT2A | |
| Clioquinol SCHEMBL11749381 | 1.00 | KDM4E (1.00) | KDM4ELMNAMEN1HTTKMT2A | |
| Clioquinol SCHEMBL27671588 | 0.98 | KDM4E (0.97) | KDM4ELMNAMEN1HTTKMT2A | |
| Clioquinol SCHEMBL18985133 | 0.98 | KDM4E (0.97) | KDM4ELMNAMEN1HTTKMT2A | |
| Clioquinol SCHEMBL28198183 | 0.98 | KDM4E (0.97) | KDM4ELMNAMEN1HTTKMT2A | |
| Clioquinol SCHEMBL28531298 | 0.98 | KDM4E (0.97) | KDM4ELMNAMEN1HTTKMT2A | |
| Clioquinol SCHEMBL28529781 | 0.98 | KDM4E (0.97) | KDM4ELMNAMEN1HTTKMT2A | |
| Clioquinol SCHEMBL28524321 | 0.98 | KDM4E (0.97) | KDM4ELMNAMEN1HTTKMT2A | |
| Clioquinol SCHEMBL9339556 | 0.98 | KDM4E (0.97) | KDM4ELMNAMEN1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 13819 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106952-A1 | METHODS FOR TREATING CONGENITAL DISORDERS OF GLYCOSYLATION | CDG CARE (US) | 2026-05-21 | — | — | WO | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-4719412-A1 | 2,8-DIHYDROXYQUINOLINE GLUCURONIDE DERIVATIVES WITH ENHANCED PROPERTIES FOR USE AS ANTICANCER, ANTIVIRAL, ANTIMICROBIAL, AND OTHER THERAPEUTIC APPLICATIONS | Westol, LLC (US) | 2026-04-08 | — | — | EP | claimed |
| US-12590963-B2 | Anti-cancer treatment of preselected subjects and screening methods to identify susceptible subjects | TUDAG TU DRESDEN AKTIENGESELLSCHAFT (DE) | 2026-03-31 | — | — | US | claimed |
| EP-4640714-A2 | METHODS FOR ASSESSING RISK OF DEVELOPING A VIRAL DISEASE USING A GENETIC TEST | PML Screening, LLC (US) | 2025-10-29 | — | — | EP | claimed |
| EP-4632063-A2 | COPPER LOSS MITIGATION | GENENTECH, INC. (US) | 2025-10-15 | — | — | EP | claimed |
| EP-3824059-B1 | CLEANING COMPOSITION WITH CORROSION INHIBITOR | ENTEGRIS INC (US) | 2025-09-17 | — | — | EP | claimed |
| US-20250248940-A1 | Biopolymer Formulations for Drug Delivery | 11584022 CANADA INC. (CA) | 2025-08-07 | — | — | US | claimed |
| US-20250248988-A1 | COMBINATION USES OF NITROXOLINE AND ITS ANALOGUES WITH CHEMOTHERAPIES AND IMMUNOTHERAPIES IN THE TREATMENT OF CANCERS | JIANGSU YAHONG MEDITECH CO., LTD. (CN) | 2025-08-07 | — | — | US | claimed |
| EP-4136211-B1 | COPPER LOSS MITIGATION | GENENTECH INC (US) | 2025-07-09 | — | — | EP | claimed |
| EP-0046270-B1 | NOVEL DERIVATIVES OF BIO-AFFECTING PHENOLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | INTERx RESEARCH CORPORATION (US) | 1986-05-21 | — | — | EP | claimed |
| US-4520099-A | CONTAINING AN HYDROXYQUINOLINE AS AN ANTIFOGGING AGENT | FUJI PHOTO FILM CO., LTD. (JP) | 1985-05-28 | — | — | US | claimed |
| US-4485091-A | HYDROGEN PEROXIDE, OIL IN WATER EMULSION | QUINODERM LIMITED (GB) | 1984-11-27 | — | — | US | claimed |
| EP-0035856-B1 | PHARMACEUTICAL AND DIETARY COMPOSITIONS | EFAMOL LIMITED (GB) | 1984-07-04 | — | — | EP | claimed |
| EP-0098577-A2 | Drugs for treating diarrhea caused by infection | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-01-18 | — | — | EP | claimed |
| EP-0096457-A1 | Indium complexes of substituted 8-hydroxy-quinolines, pharmaceutical compositions containing them and their use as antibacterial agents | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1983-12-21 | — | — | EP | claimed |
| EP-0046270-A1 | Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them | INTERx RESEARCH CORPORATION (US) | 1982-02-24 | — | — | EP | claimed |
| EP-0037175-A1 | Pharmaceutical compositions | EFAMOL LIMITED (GB) | 1981-10-07 | — | — | EP | claimed |
| EP-0035856-A2 | Pharmaceutical and dietary compositions | EFAMOL LIMITED (GB) | 1981-09-16 | — | — | EP | claimed |
| WO-1980000791-A1 | B-GLUCURONIDASE ACTIVITY AND/OR PH-DEPENDENT PHARMACEUTICALS AND THEIR METHODS OF PRODUCTION AND USE FOR SELECTIVE TREATMENT OF DISEASES | SCHWIMMER A (US) | 1980-05-01 | — | — | WO | claimed |